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Abstract  
 
Purpose: People with cancer and their families experience high levels of psychological 
morbidity. However many cancer services do not routinely screen patients for anxiety and 
depression and there are no standardized clinical referral pathways. This study aimed to establish 
consensus on elements of a draft clinical pathway tailored to the Australian context. 
Methods: A two-round Delphi study was conducted to gain consensus among Australian 
oncology and psycho-oncology clinicians about the validity of 39 items that form the basis of a 
clinical pathway that includes screening, assessment, referral and stepped-care management of 
anxiety and depression in the context of cancer. The expert panel comprised 87 multidisciplinary 
clinician members of the Australian Psycho-oncology Cooperative Research Group (PoCoG). 
Respondents rated their level of agreement with each statement on a 5-point likert scale. 
Consensus was defined as >80% of respondents scoring within 2 points on the likert scale. 
Results: Consensus was reached for 21 of 39 items, and a further 15 items approached consensus 
except for specific contextual factors, after 2 Delphi rounds. Formal screening for anxiety and 
depression, a stepped care model of management and recommendations for inclusion of length of 
treatment and time to review were endorsed. Consensus was not reached on items related to roles 
and responsibilities, particularly those not applicable across cancer settings.  
Conclusions: This study identified a core set of evidence- and consensus-based principles 
considered essential to a stepped care model of care incorporating identification, referral and 
management of anxiety and depression in adult cancer patients.   
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Background 
A cancer diagnosis impacts on patients’ psychological as well as physical functioning. The point 
prevalence estimate for any mood disorder in cancer patients is 20.7%, for anxiety disorders is 
10.3% , and for adjustment disorders is 19.4% [1]. Early detection and treatment of anxiety and 
depression symptoms not only reduce patient suffering and the likelihood of developing a major 
mood disorder, but directly impact on the health service through increased treatment adherence 
and lower health service utilisation [2]. However, despite being readily treatable and having a 
strong evidence-base for interventions [3-5], anxiety/depression are often undetected, overlooked 
and their severity underestimated [6] in busy cancer services.  
To address under-detection of psychological distress, routine screening of all cancer patients 
using validated, reliable, objective measures, is internationally endorsed [7] and demonstrated to 
be feasible and acceptable within the cancer setting [8]. Canada has established that national 
screening for distress in the cancer setting can be implemented [9]. Screening programs at a 
regional level have also been implemented successfully [10], yet in many countries screening is 
not standard practice, and is highly variable where it does occur. Reasons for not screening are 
multifactorial [11] but lack of referral guidance is reported by clinicians to be a major deterrent 
[12]. A number of systematic reviews also report appropriate care after screening to be the most 
significant predictor of improved patient outcomes [13, 14, 15].  
 
Clinical pathways (multidisciplinary management plans that standardise care [16]), combined 
with audit and staff training, have the potential to increase the occurrence, accuracy and 
consistency of distress screening and management, and therefore patient outcomes [17]. Existing 
international clinical practice guidelines [18-21] have raised awareness and acceptance of 
psychosocial care as integral to multi-disciplinary care, but lack the specific guidance that is the 
hallmark of effective clinical pathways, and evidence-based tailored implementation strategies to 
embed recommended strategies into routine care [22]. Our group is developing an evidence-
based stepped-care clinical pathway for managing anxiety and depression in cancer patients. An 
initial draft, based on existing literature, reviews and guidelines, was refined after extensive 
feedback from semi-structured interviews with 12 multidisciplinary experts [23].  This process 
identified some uncertainties regarding key elements of the pathway.  
Therefore, the aim of this study was to engage a large and representative group of health 
professionals providing clinical care for cancer patients to reach consensus on a clinical pathway 
for the identification and management of anxiety/depression in adult cancer patients. Frontline 
clinical staff rather than researchers were approached, as successful implementation requires the 
pathways to be clinically relevant and reflective of existing services and resources.  
 
Methods 
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Participants 
Participants were selected from the membership database of the Psycho-oncology Co-operative 
Clinical Trials Group (PoCoG), a national cancer clinical trials group in Australia comprising 
over 1100 clinicians and/or researchers from multiple disciplines interested in psycho-oncology. 
PoCoG membership comprises approximately 36% psychologists, 11.5% nursing, 9.4% medical, 
7.6% social work, 3.8% palliative care, 1.7% psychiatry. Initial participant selection was based 
on even representation across disciplines.  
Health professionals were eligible for the study if they were: clinically active, working primarily 
in oncology in Australia and able to respond to the first round of the survey within six weeks. 
Approximately 247 health professionals were purposefully sampled to include a range of a) 
disciplines (medical and radiation oncologists, nurses, psychologists, social workers, palliative 
care physicians, psychiatrists, general practitioners and cancer surgeons); b) genders; c) 
Australian states and territories; and d) rural/regional and metropolitan settings.   
Design 
An initial draft pathway was developed, guided by existing literature, reviews and guidelines. 
This was refined after extensive feedback from semi-structured interviews with 12 
multidisciplinary experts [23].  This process identified some uncertainty around key 
recommendations made by the pathway. The key elements fell into six domains: (1) adapting and 
implementing the pathways into the Australian cancer care system; (2) formalised screening; (3) 
identification and  severity assessment of anxiety/depression; (4) a stepped care model of 
referral/management; (5) monitoring and care co-ordination and (6) professional roles. 39 
statements comprising areas of uncertainty with each of the domains were developed by a 
multidisciplinary advisory committee (see Figure 1 and Table 2). Each statement was framed to 
elicit an agreement/disagreement response from survey participants, with accompanying free text 
to encourage  participants to comment on the underlying reasons for their response. 
 
Potential participants were invited to participate via email providing a link to the password 
protected online survey (Limesurvey, version 1.91). Participants consented online and completed 
demographic questions prior to completing the 20 minute survey. In each round of feedback 
participants indicated their agreement with each item on a 5 point likert scale from strongly 
disagree to strongly agree. Participants were also able to provide comments for each individual 
item.  
Consensus for an item was defined as 80% or more of respondents rating the item within two 
points on the scale [24]. Participants were asked to re-rate items that failed to reach consensus in 
light of group responses, in subsequent rounds, until sufficient feedback had been received. Non-
responders were emailed up to three reminders over three weeks for each round.  
5 
 
The study was approved by University of Sydney ethics committee. 
Data Analysis 
Results were analysed in total and per discipline. Descriptive statistics were used to report level 
of consensus. A two-tailed Kruskal-Wallis exact test (p values <.05 considered statistically 
significant) was used to assess inter-discipline differences for items that failed to reach 
consensus. Data were analysed using SPSS Statistics 20 (IBM., Armonk, NY, USA). Free text 
comments for individual items were content-analysed to further explore participant responses. 
Results 
Of 247 potentially eligible participants approached via email, 87 (35.2%) completed the first 
round and 60 (69%) completed a second round of the Delphi survey. The expert panel was 
multidisciplinary, provided national representation, were mostly employed in the public hospital 
system and based at a tertiary referral cancer centre, and had worked in oncology an average of 
13.6 years (range 1.5-18 years; SD 8.0) (see Table 1). There were no significant differences 
between responders and non-responders in terms of gender, discipline or state of residence. No 
further demographic information was collected from non-participating clinicians. 
Figure 1 provides an overview of the consensus process. Thirty-nine items were presented in 
Round 1, and 19 in Round 2. Eighteen items remained unresolved at the end of Round 2. The 
research team reviewed responses to these items together with qualitative responses, and four 
items were accepted as resolved as they approached the consensus definition (75-78% 
agreement). There was broad agreement for a further 11 items, although there was some 
disagreement regarding specific contexts; these were resolved with contextual re-wording. 
Subsequently, the multidisciplinary stakeholder advisory committee verified that these revised 
items reflected the comments provided as part of the qualitative feedback. There was no 
consensus for two items, related to practical and spiritual concerns and their relationship to 
anxiety/depression. Following consultation with the advisory committee these items were judged 
non-essential and removed from the pathway. Two rounds of feedback were judged sufficient, as 
further rounds were thought unlikely to result in change.  
Table 2 presents individual items grouped by domain and the level of consensus for each item in 
descending order. Table 3 presents the inter-discipline differences for items where consensus 
was not reached. Each set of items is discussed below.  
Adapting and implementing clinical pathways in the local setting 
Greater than 90% agreement was reached on the three items in this domain. Participants agreed 
that key members of the treatment team should decide together how best to adapt and implement 
the pathways in their own institution or clinical setting and that local resources, such as available 
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staff and budgets, as well as patient characteristics, need to be considered in adapting the 
pathways. 
Screening for anxiety/depression 
Consensus was reached on 2/6 items in this domain: that screening should be routinely 
implemented and formalised. A third item, specifying that specific staff be formally responsible 
for screening, but that all staff ask patients about distress and alert designated staff about 
potentially distressed patients, narrowly missed our consensus threshold.  
On three items no consensus was reached, related to specific methods of screening which could 
be viewed as prescriptive. There was 50% agreement that a two-step approach was the most 
appropriate. Some thought a clinical interview was more appropriate to identify the level and 
nature of anxiety/depression, with considerable inter-professional disagreement on this item 
(Table 3). Nurses were most likely to endorse a two-step screening assessment (79%, x=3.7; 
SD1.2), psychologists least likely to endorse this (20%, x=2.5; SD1.4), and medical practitioner 
ratings were in between (45%, x=3.1; SD 1.1).   
No consensus was reached for the cancer nurse coordinator (CNC) being the most appropriate 
person to be responsible for screening. Some cited the high workload of CNCs, or noted that 
CNCs may not see all patients, and had variable mental health experience and training. While the 
rating of agreement was comparable across most discipline groups (40%-45%), the exception 
was among the social workers (22%), suggesting differing perceptions of roles across disciplines.   
There was also no consensus for the Edmonton Symptom Assessment System (ESAS) [25] being 
the most appropriate screening tool. Some noted the ESAS was not well known, while other 
screening tools, such as the distress thermometer [26] were more familiar and being used in 
clinical practice. Again, there was considerable inter-disciplinary variation (Table 3), with those 
endorsing the ESAS ranging from 7% by nurses, 22% by social workers, 25% by oncology 
medical disciplines, 40% by psychologists, to 57% from the mixed group of ‘other’ disciplines, 
although this difference was not statistically significant. 
Assessment and Referral 
Strong consensus was reached on 5/7 items in this domain (Table 2), including: accommodating 
patient preferences, patient education to maximise uptake of services, normalising distress 
following diagnosis and treatment, further assessment to clarify the nature and severity of 
anxiety/depression, and discussing screening results with patients. 
Participants largely disagreed about whether screening and subsequent assessment should be 
carried out simultaneously by the same staff member or sequentially. Nurses viewed 
simultaneous screening and assessment more favourably than other professional groups (3.7 vs 
2.7, Krsukal Wallis, p<.018). This disagreement arose from concern that while nurses were likely 
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to conduct screening, they are not specifically trained to conduct in-depth psychological 
assessments.  
Stepped Care Clinical Pathway Model 
Consensus was reached for 5/13 items in this domain (Table 2). The consensus included: 
reporting progress back to the treating team, length of treatment and review time being decided 
by the treating clinician, that nurses, oncologists and GPs are best placed to monitor and follow 
up lower levels of distress, while for moderate to severe distress, specialist mental health 
professionals assume the responsible for ongoing monitoring and follow up.  There was also 
agreement that a stepped care model for managing anxiety/depression is appropriate. 
Several factors related to management of distress narrowly missed our consensus threshold: that 
mild distress should be managed according to patient preference and staff availability, that 
specific treatment be at the clinician discretion and for the appropriateness of specific treatment 
options recommended.  
In contrast, there was disagreement concerning whether practical and spiritual concerns overlap 
with anxiety and distress or should be treated separately, whether treatment time frames be 
specified within the pathways, the role of the GP in treating moderate to severe distress in rural 
and regional areas, as well as very low agreement about whether the stepped care model is too 
rigid for variability in managing anxiety/depression in cancer patients. Inter-disciplinary 
disagreement on these items was not statistically significant.   
Monitoring and Care Coordination 
Consensus was reached for 6/7 items in this domain (Table 2), including reporting patient 
progress back to the treatment team and care coordinator and that the person responsible for 
coordination of care will depend on local staffing, resources, patient factors and preferences, and 
that nurses, oncologists and GPs be responsible for monitoring and follow up those with lower 
levels of anxiety/depression, while specialised mental health professionals have this 
responsibility for those with high levels of anxiety/depression.    
There was disagreement about whether one person should be designated as responsible for 
coordination of care for anxiety/depression, as not always being feasible, excluding valuable 
team management, while increasing the likelihood of some patients being overlooked.  
Professional Roles 
There was disagreement for three items related to professional roles (Table 2), with only 68% 
agreement for the different professional roles recommended. Free text comments indicated that 
individual psychosocial training, capacity and experience were more important that role 
designation at individual institutions. Some perceived the role of nurses and social workers in 
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psychosocial care was over-stated, while others highlighted social workers’ training in delivery 
of psychological counselling.  
There was also disagreement with the recommended level of involvement by GPs, with concerns 
about availability, time constraints within a busy GP practice and skill level in delivery of 
psychosocial care. There were significant differences between disciplines (Table 3) about this 
(3.7 vs 3.1, Krsukal Wallis, p<.02), with social workers reporting 78% agreement that GP 
involvement was unrealistic, medical respondents reported only 20% agreement, and other 
disciplines in between (40-43%).  
Discussion 
This paper reports on consensus reached by key health professional stakeholders concerning 
components of a clinical pathway for the identification and management of anxiety and 
depression in adult cancer care. Our results confirmed multidisciplinary support for routine 
formal screening of anxiety/depression in oncology, combined with a stepped-care model of 
treatment and review. A key factor in the successful translation of pathways into practice is 
ownership by all health professionals during the development phase [16].  
Unlike clinical practice guidelines, pathways are most effective in facilitating change if they 
provide sufficient flexibility to enable treatment centres to adapt them for the local setting [27]. 
Feedback from stakeholders confirms that the content and recommendations within the pathway 
provided sufficient detail without being too rigid or prescriptive. Consistent with previous 
literature [28,29], participants agreed key members of each treatment team need to tailor the 
pathways together for their own institution/clinical setting, according to available resources, 
expertise and the needs of their patient population.  
Inter-professional differences in understanding of specific aspects of specialist training were 
observed and unsurprisingly each discipline reflected on the pathway from their own 
professional role/perspective. For example, as a group, nurses were confident in their ability to 
assess level of anxiety/depression, while other professional groups suggested social workers and 
psychologists needed to conduct more detailed assessments. Similarly, disagreement regarding 
the role of the general practitioner in managing moderate to severe anxiety/depression in rural 
and regional areas reflects the disparity in services available between metropolitan and regional 
centres and the role of the GP in the delivery of psychological care more generally. Local 
tailoring of the pathway based on an individual centre’s staff experience and resourcing, as well 
as inclusion of education / training regarding roles and responsibilities and collaborative 
discussions with team members, as part of the structured implementation of the pathway at a 
local level will address some of the inter-professional differences observed in this study.  
There was little support for inclusion of practical and spiritual issues in the pathway, contrasting 
with recommendations from the clinical practice guidelines for psychosocial care [21]. The 
reason for this is unclear and may reflect health professionals’ discomfort with exploring 
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spiritual issues. Alternatively health professionals may feel this is better explored in an in-depth 
interview outside of the initial screening process.   
The need for flexibility in pathway implementation was also evident in the lack of consensus on 
screening methods, specifically whether a formal clinical interview is required prior to referral.  
There was also little agreement regarding the recommendation of the (ESAS)[25] as a screening 
tool, due in part to unfamiliarity with the ESAS, and more familiarity with the distress 
thermometer [26]. Such a result is not surprising given the study sample was drawn not from 
specialist psycho-oncologists but more broadly from oncology clinicians who may be unfamiliar 
with the psychometric properties of tools and base selection on familiarity with a measure or 
factors such as time and ease of completion. As part of implementation of the pathway, inclusion 
of education and training related to the relative merits of different screening tools will help 
clinicians to select an appropriate standardised screening measure. 
A limitation of this study is that the findings are based on a sample of 87 Australian oncology 
professionals. Although the response rate was low, such response rates are common for web-
based survey research [30], and oversampling was deliberately undertaken to ensure the sample 
size was adequate for a Delphi study [31]. Furthermore, participants were purposively selected to 
represent the multidisciplinary diversity of health professionals providing cancer care in 
Australia. Despite this multidisciplinary sample potentially resulting in less consensus, we 
consider that the sample of active clinicians, rather than researchers or policy-makers, reflects 
the reality of multidisciplinary practice and is a strength of the study. Gaining consensus from 
clinicians has resulted in a pathway that reflects existing services and resources rather than a 
wish list of unfunded or unsustainable services. The model used in this study therefore provides a 
blueprint for other countries to utilise when developing local evidence-based clinical pathways, 
regardless of the level available psychosocial services.  
Another limitation of the methodology  utilised is the lack of interaction between participants, 
which prevented in-depth discussion to gain understanding of inter-disciplinary differences. 
However, we did provide written feedback to participants on others’ comments, and they had the 
opportunity to comment again in the 2nd round. Thus we did receive feedback on inter-
disciplinary issues.  
Despite the limitations, our results confirm the proposed clinical pathway as a useful tool in 
improving implementation of screening and evidence-based interventions for anxiety and/or 
depression.  Of course, reaching consensus regarding key features of the clinical pathway is only 
the first step in implementing a pathway. Work is ongoing to develop and evaluate an on-line 
version of the clinical pathway to facilitate easy access in cancer centres across Australia. This 
on-line version will incorporate resources and templates to assist centres to develop and 
document their local pathway. As part of this research program we will also systematically 
evaluate and address barriers to implementation. Models of behaviour change and 
implementation science will guide strategies for system uptake. Implementation of routine 
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distress screening programs in Canada and the US provides practical guidance for successful 
implementation [9,10, 32] as the barriers and facilitators identified were similar to those 
identified in our pilot research [23]. Recommendations related to active engagement with local 
teams and identification of local champions [16,33 ] have informed our approach to local 
implementation. An educational outreach program, an important component of change 
management within healthcare [34], is also currently being piloted.  
If successful, this program of work will integrate effective screening, detection and management 
of anxiety and depression into Australian cancer services, in a sustainable and effective manner 
that empowers patients and family members towards self-care, up-skills all health professionals 
in effective care, and allows psychosocial staff to focus on the most serious cases that need their 
expert input. 
Conclusions 
This study used a Delphi process to reach consensus about elements essential to the identification 
and management of anxiety and depression in adult cancer patients. Our findings confirm 
clinicians are amenable to implementing a clinical pathway for anxiety and depression as part of 
standard practice in cancer care. The recommendation of a stepped care model was endorsed. 
The pathway now requires implementation and evaluation. 
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